MedPath

amiloride hydrochloride

Amiloride HCl Tablets, USP

Approved
Approval ID

2b70cf0c-45be-428f-b396-5001ed4e30fc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 30, 2022

Manufacturers
FDA

Padagis US LLC

DUNS: 967694121

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

amiloride hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0574-0292
Application NumberNDA018200
Product Classification
M
Marketing Category
C73605
G
Generic Name
amiloride hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateApril 30, 2022
FDA Product Classification

INGREDIENTS (5)

AMILORIDE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: FZJ37245UC
Classification: ACTIR
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

amiloride hydrochloride - FDA Drug Approval Details